Discover a study introducing MAARS, a multimodal AI model that accurately predicts sudden cardiac death risk in HCM patients.

The capital injection will support the company in progressing trials and obtaining clearances from health regulatory ...

Key Takeaways Tempus AI stock shows 15–32% upside potential based on analyst forecasts.The company leads in using artificial ...

India's wearables market is exploding! Know how affordable smartwatches and fitness trackers are democratizing health monitoring & revolutionizing athlete performance in India.

Europe clinical trials market was valued at valued at $10,939.1 million in 2022 and will grow by 6.4% annually over 2022-2031, driven by the increasing number of clinical trials and increase in demand ...

For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2031. The breakdown of all regional markets by country and split of each ...